Frontiers in Medicine (May 2022)
Fetal Liver Volume Assessment Using Magnetic Resonance Imaging in Fetuses With Cytomegalovirus Infection†
- Ameth Hawkins-Villarreal,
- Ameth Hawkins-Villarreal,
- Ameth Hawkins-Villarreal,
- Ameth Hawkins-Villarreal,
- Ana L. Moreno-Espinosa,
- Ana L. Moreno-Espinosa,
- Ana L. Moreno-Espinosa,
- Ana L. Moreno-Espinosa,
- Raigam J. Martinez-Portilla,
- Raigam J. Martinez-Portilla,
- Raigam J. Martinez-Portilla,
- Karen Castillo,
- Karen Castillo,
- Nadine Hahner,
- Nadine Hahner,
- Ayako Nakaki,
- Ayako Nakaki,
- Lucas Trigo,
- Lucas Trigo,
- Olivier Picone,
- Nathalie Siauve,
- Francesc Figueras,
- Francesc Figueras,
- Francesc Figueras,
- Alfons Nadal,
- Alfons Nadal,
- Alfons Nadal,
- Elisenda Eixarch,
- Elisenda Eixarch,
- Elisenda Eixarch,
- Anna Goncé,
- Anna Goncé,
- Anna Goncé
Affiliations
- Ameth Hawkins-Villarreal
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Ameth Hawkins-Villarreal
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Ameth Hawkins-Villarreal
- Fetal Medicine Service, Department of Obstetrics, Hospital “Santo Tomás”, University of Panama, Panama City, Panama
- Ameth Hawkins-Villarreal
- Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico
- Ana L. Moreno-Espinosa
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Ana L. Moreno-Espinosa
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Ana L. Moreno-Espinosa
- Fetal Medicine Service, Department of Obstetrics, Hospital “Santo Tomás”, University of Panama, Panama City, Panama
- Ana L. Moreno-Espinosa
- Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico
- Raigam J. Martinez-Portilla
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Raigam J. Martinez-Portilla
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Raigam J. Martinez-Portilla
- Iberoamerican Research Network in Obstetrics, Gynecology and Translational Medicine, Mexico City, Mexico
- Karen Castillo
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Karen Castillo
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Nadine Hahner
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Nadine Hahner
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Ayako Nakaki
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Ayako Nakaki
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Lucas Trigo
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Lucas Trigo
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Olivier Picone
- Department of Gynaecology and Obstetrics, Hôpital Louis Mourier, Hôpitaux Universitaires Paris Nord, APHP, Université Paris Diderot, Paris, France
- Nathalie Siauve
- Department of Radiology, Hôpital Louis-Mourier, Hôpitaux Universitaires Paris Nord, APHP, Université Paris Diderot, Paris, France
- Francesc Figueras
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Francesc Figueras
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Francesc Figueras
- Centre for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain
- Alfons Nadal
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Alfons Nadal
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Alfons Nadal
- Department of Clinical Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain
- Elisenda Eixarch
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Elisenda Eixarch
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Elisenda Eixarch
- Centre for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain
- Anna Goncé
- BCNatal - Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Universitat de Barcelona, Barcelona, Spain
- Anna Goncé
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Anna Goncé
- Centre for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain
- DOI
- https://doi.org/10.3389/fmed.2022.889976
- Journal volume & issue
-
Vol. 9
Abstract
ObjectiveTo assess fetal liver volume (FLV) by magnetic resonance imaging (MRI) in cytomegalovirus (CMV)-infected fetuses compared to a group of healthy fetuses.MethodMost infected cases were diagnosed by the evidence of ultrasound abnormalities during routine scans and in some after maternal CMV screening. CMV-infected fetuses were considered severely or mildly affected according to prenatal brain lesions identified by ultrasound (US)/MRI. We assessed FLV, the FLV to abdominal circumference (AC) ratio (FLV/AC-ratio), and the FLV to fetal body volume (FBV) ratio (FLV/FBV-ratio). As controls, we included 33 healthy fetuses. Hepatomegaly was evaluated post-mortem in 11 cases of congenital CMV infection. Parametric trend and intraclass correlation analyses were performed.ResultsThere were no significant differences in FLV between infected (n = 32) and healthy fetuses. On correcting the FLV for AC and FBV, we observed a significantly higher FLV in CMV-infected fetuses. There were no significant differences in the FLV, or the FLV/AC or FLV/FBV-ratios according to the severity of brain abnormalities. There was excellent concordance between the fetal liver weight estimated by MRI and liver weight obtained post-mortem. Hepatomegaly was not detected in any CMV-infected fetus.ConclusionIn CMV-infected fetuses, FLV corrected for AC and FBV was higher compared to healthy controls, indicating relative hepatomegaly. These parameters could potentially be used as surrogate markers of liver enlargement.
Keywords
- magnetic resonance imaging
- fetal liver
- pregnancy
- fetal cytomegalovirus infection
- fetal brain abnormalities